Extracorporeal Shock Wave Therapy on Neuropathic Pain Post Mastectomy
Recruiting
N/A
Interventional Study
Neuropathic Pain
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 40 – 65
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Cairo University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
PURPOSE: The main objective of the study is:
to evaluate the therapeutic effect of ESWT on intercostobrachial neuralgia post-mastectomy.
BACKGROUND:
Intercostobrachial neuralgia post-mastectomy is thought to develop from surgical damage to the intercostobrachial nerve, this nerve is injured in 80-100 % of mastectomy patients who undergo axillary lymph nodes dissection.
Pain that is localized i…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age range will be from 40 to 65 years.
2. All patients will be female patients suffering from intercostobrachial neuralgia after unilateral modified radical mastectomy.
3. All patients suffering from moderate or severe pain of burning, tingling, numbness, and electric nature …
Contacts
No contact information available.